According to Arvinas's latest financial reports the company has a price-to-book ratio of 3.35.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 3.43 | 6.46% |
2022-12-31 | 3.22 | -41.98% |
2021-12-31 | 5.56 | -11.19% |
2020-12-31 | 6.26 | -11.46% |
2019-12-31 | 7.06 | 132.27% |
2018-12-31 | 3.04 | |
2017-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | 2.43 | -27.58% | ๐บ๐ธ USA |